Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Intracerebral Injection of Streptozotocin to Model Alzheimer Disease in Rats

Full text
Moreira-Silva, Daniel [1, 2] ; Vizin, Robson C. L. [1, 3] ; Martins, Talita M. S. [4] ; Ferreira, Tatiana L. [5] ; Almeida, Maria C. [6] ; Carrettiero, Daniel C. [6]
Total Authors: 6
[1] Fed Univ ABC, Grad Program Neurosci & Cognit, Sao Bernardo Do Campo - Brazil
[2] Univ Fed Uberlandia, Inst Biomed Sci, Dept Pharmacol, Uberlandia, MG - Brazil
[3] St Josephs Hosp, Trauma Res, Thermoregulat & Syst Inflammat Lab FeverLab, Phoenix, AZ - USA
[4] Fed Univ ABC, Undergrad Program Neurosci, Sao Bernardo Do Campo - Brazil
[5] Fed Univ ABC, Ctr Math Comp & Cognit, Sao Bernardo Do Campo - Brazil
[6] Fed Univ ABC, Ctr Nat & Human Sci, Sao Bernardo Do Campo - Brazil
Total Affiliations: 6
Document type: Journal article
Source: BIO-PROTOCOL; v. 9, n. 20 OCT 20 2019.
Web of Science Citations: 0

Animal models have promoted meaningful contribution to science including Alzheimer's disease (AD) research. Several animal models for AD have been used, most of them related to genetic mutations observed in familial AD. However, sporadic form of AD, also named late-onset is the most frequent form of the disease, which is multifactorial, being influenced by genetic, environmental and lifestyle factors. Here, we describe a protocol of an AD-like pathology of the sporadic form using Wistar rats by a single bilateral intracerebroventricular (icy) injection of streptozotocin (STZ, 2 mg/kg). Icy injection of STZ induces brain resistance to insulin and other pathological alterations related to those observed in AD, such as cognitive impairment and accumulation of phosphorylated tau protein and beta-amyloid in the brain. Thus, icy injection of STZ is a useful tool to investigate the pathological mechanisms and the metabolic alterations involved in AD and to propose new therapeutic approaches and neuroprotective drugs. (AU)

FAPESP's process: 14/14661-1 - Role of cannabinoid system on tau activity and its relation to the cognitive performance in a model of sporadic Alzheimer's Disease in rats
Grantee:Daniel Moreira Silva
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 17/12648-6 - Effect of environmental temperature on behavioral parameters in animal model for Alzheimer's Disease
Grantee:Talita Maria Senra Martins
Support type: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 15/23426-9 - Beta-amyloid in Alzheimer's Disease: death or survival? Involvement of NF-kappaB and BAG2
Grantee:Daniel Carneiro Carrettiero
Support type: Regular Research Grants
FAPESP's process: 16/24773-7 - Possible preventive effect of anandamide on alterations of neuroplasticity and modulation of endocannabinoid system induced by streptozotocin
Grantee:Daniel Moreira Silva
Support type: Scholarships abroad - Research Internship - Doctorate
FAPESP's process: 15/02991-0 - Involvement of TRPM8 channels in thermoregulation of Wistar rats
Grantee:Maria Camila Almeida
Support type: Regular Research Grants